3 recruiting, 1 completed. 2 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Advanced Urothelial Cancer: new trials by email Literature Review of Advanced Urothelial Cancer trials Research Report on Advanced Urothelial Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy Acupuncture, Exercise - Metastatic Bladder Cancer, Peripheral Neuropathy | Not applicable | Recruiting | Dana-Farber Cancer Institute | 20 | 2026-09-03 | 2026-10-26 |
| Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer GB-4362, enfortumab vedotin (EV), Pembrolizumab - Advanced Urothelial Cancer, Metastatic Urothelial Carcinoma | Phase 1 | Recruiting | Generate Biomedicines | 37 | 2026-06-08 | 2026-10-13 |
| Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers Biological samples collection, questionnaires to collect patient reported outcomes - Advanced Breast Cancer, Advanced Gastric Cancer | Phase 2 | Recruiting | UNICANCER | 400 | 2025-11-14 | 2025-12-02 |
| A Study Evaluating Chemotherapy With Fractionated Cisplatin/Gemcitabine Versus Carboplatin/Gemcitabine in the Treatment of Advanced or Metastatic Urothelial Cancer With Impaired Renal Function. Carboplatin, Fractionated Cisplatin, Gemcitabine - Advanced Urothelial Cancer, Metastatic Urothelial Cancer | Phase 2 / Phase 3 | Completed | Institut Claudius Regaud | 46 | 2015-01-21 | 2019-08-09 |
Peripheral Nervous System Diseases (2) · Carcinoma, Transitional Cell (1) · Urinary Bladder Neoplasms (1)
Neoplasms (2) · Nervous System Diseases (2) · Neuromuscular Diseases (2) · Carcinoma (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Male Urogenital Diseases (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Urinary Bladder Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Urologic Diseases (1) · Urologic Neoplasms (1)
Acupuncture Therapy (1) · Carboplatin (1) · Exercise (1) · Gemcitabine (1) · enfortumab vedotin (1) · pembrolizumab (1)
Dana-Farber Cancer Institute (1) · Generate Biomedicines (1) · Institut Claudius Regaud (1) · UNICANCER (1)
France (2) · United States (2)
Barbara Pistilli, MD, PhD (1) · Christina Dieli-Conwright, PhD, MPH (1)